@article{e16e71a5aa0947ceaa3a1cccf96e7a94,
title = "A novel somatic mutation achieves partial rescue in a child with hutchinson-gilford progeria syndrome",
abstract = "Background Hutchinson-Gilford progeria syndrome (HGPS) is a fatal sporadic autosomal dominant premature ageing disease caused by single base mutations that optimise a cryptic splice site within exon 11 of the LMNA gene. The resultant disease-causing protein, progerin, acts as a dominant negative. Disease severity relies partly on progerin levels. Methods and results We report a novel form of somatic mosaicism, where a child possessed two cell populations with different HGPS disease-producing mutations of the same nucleotide-one producing severe HGPS and one mild HGPS. The proband possessed an intermediate phenotype. The mosaicism was initially discovered when Sanger sequencing showed a c.1968+2T>A mutation in blood DNA and a c.1968 +2T>C in DNA from cultured fibroblasts. Deep sequencing of DNA from the proband's blood revealed 4.7% c.1968+2T>C mutation, and 41.3% c.1968 +2T>A mutation. Conclusions We hypothesise that the germline mutation was c.1968+2T>A, but a rescue event occurred during early development, where the somatic mutation from A to C at 1968+2 provided a selective advantage. This type of mosaicism where a partial phenotypic rescue event results from a second but milder disease-causing mutation in the same nucleotide has not been previously characterised for any disease.",
author = "Bar, {Daniel Z.} and Arlt, {Martin F.} and Brazier, {Joan F.} and Norris, {Wendy E.} and Campbell, {Susan E.} and Peter Chines and Delphine Larrieu and Jackson, {Stephen P.} and Collins, {Francis S.} and Glover, {Thomas W.} and Gordon, {Leslie B.}",
note = "Funding Information: The authors are extremely grateful to the children and families for participation in this study. They thank the University of Michigan Sequencing Core for assistance. They also thank Drs. Thorsten Marquardt and Janine Reunert for additional assistance. Progeria experiments were funded by The Progeria Research Foundation grants PRF-2002-CB and PRF-2002-MRD ( JFB, WEN, SEC, LBG), and by the Medical Research Council UK grant MR/L019116/1 (DL). Core and general laboratory grants are as follows: Kilguss Research Core of Women & Infants Hospital of Rhode Island through an Institutional Development Award from the NIGMS of the NIH (P30GM114750), intramural funds to the NHGRI (ZIA-HG200305), Cancer Research UK programme grant C6/A18796 and Wellcome Trust (WT092096).",
year = "2017",
month = mar,
day = "1",
doi = "10.1136/jmedgenet-2016-104295",
language = "אנגלית",
volume = "54",
pages = "212--216",
journal = "Journal of Medical Genetics",
issn = "0022-2593",
publisher = "BMJ Publishing Group",
number = "3",
}